卵巢类癌诊治中国专家共识(2025年版)  

Chinese expert consensus on the diagnosis and treatment of ovarian carcinoid(2025 Edition)

作　　者：中国抗癌协会中西整合卵巢癌专业委员会 张颐[2] 王玉东[3] 张师前[4] 苏英杰 芦恩婷 梁静[5] 程静新[6] 王志启 李长忠 孙蓬明[9] 刘军秀[10] Chinese and Western Integrated Ovarian Cancer Professional Committee of China Anti-Cancer Association(Chinese and Western Integrated Ovarian Cancer Professional Committee of China Anti-Cancer Association)

机构地区：[1]不详 [2]中国医科大学附属第一医院 [3]上海交通大学医学院附属国际和平妇幼保健院 [4]山东大学齐鲁医院 [5]中日友好医院 [6]同济大学东方医院 [7]首都医科大学附属友谊医院 [8]北京大学深圳医院 [9]福建省妇幼保健院 [10]中山大学附属第一医院

出　　处：《癌症进展》2025年第6期621-626,657,共7页Oncology Progress

基　　金：辽宁省应用基础研究计划项目(2022JH2/101300039);沈阳市科技计划项目(22-321-33-08);沈阳市科技局2023年助力中国医科大学高质量发展专项(23-506-3-01-10)。

摘　　要：类癌是一种源自胃肠道系统及其他器官内分泌细胞的神经内分泌肿瘤,具有低度恶性潜能,其中,卵巢类癌是一种极为罕见、高度分化的神经内分泌肿瘤,通常伴有囊性成熟性畸胎瘤,被归类为生殖细胞肿瘤。与胃肠道原发的类癌相比,目前临床对于卵巢类癌病理生理机制的认知尚显不足,且针对卵巢类癌的最佳治疗方案尚无明确定论。本共识以现有的文献证据为基础,分析并明确卵巢类癌可能出现的临床表现并推荐适宜的诊断、治疗方式。Carcinoid are a type of neuroendocrine tumor that originate from endocrine cells in the gastrointestinal system and other organs,with low malignant potential.Among them,ovarian carcinoid are extremely rare,highly differentiated neuroendocrine tumors,often accompanied by cystic mature teratomas,and are classified as germ cell tumors.Compared with primary carcinoid in the gastrointestinal tract,the current clinical understanding of the pathophysiological mechanism of ovarian carcinoid is still insufficient,and there is no clear consensus on the best treatment plan for ovarian carcinoid.This consensus is based on existing literature evidence,analyzes and clarifies the possible clinical manifestations of ovarian carcinoid,and recommends appropriate diagnostic and treatment methods.

关 键 词：类癌 卵巢类癌 类癌综合征 专家共识 

分 类 号：R737.31[医药卫生—肿瘤]